Documentation
Data on biomarker prevalence in Non-Small Cell Lung Cancer in Belgium
Last updated: 2023-02-03 03:36
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria
Last updated: 2023-02-03 03:36